These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 3134517

  • 1. Long-term safety and efficacy comparison of immediate-release and sustained-release oral verapamil in systemic hypertension.
    Frishman WH, Eisen G, Charlap S, Strom JA.
    J Clin Hypertens; 1987 Dec; 3(4):605-9. PubMed ID: 3134517
    [Abstract] [Full Text] [Related]

  • 2. A new sustained-release formulation of verapamil in the treatment of hypertension.
    Midtbo KA, Hals O, Lauve O.
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):125S-132S. PubMed ID: 3540222
    [Abstract] [Full Text] [Related]

  • 3. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
    Hilleman DE, Mohiuddin SM, Lucas BD, Shinn B, Elsasser GN.
    Clin Ther; 1993 Sep; 15(6):1002-10. PubMed ID: 8111798
    [Abstract] [Full Text] [Related]

  • 4. Antihypertensive efficacy of sustained-release verapamil.
    Zachariah PK, Sheps SG, Oshrain C, Schirger A, Stein WJ.
    J Clin Hypertens; 1987 Dec; 3(4):536-46. PubMed ID: 3330987
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of enalapril and sustained-release verapamil in older patients with mild to moderate essential hypertension.
    Weir MR, Cassidy CA, Hall PS, Lancaster A, Schubert C, Urick A, Saunders E, Kong BW, Jenkins P, Lavin PT.
    Clin Ther; 1990 Dec; 12(2):139-48. PubMed ID: 2354483
    [Abstract] [Full Text] [Related]

  • 6. Verapamil SR and propranolol LA: a comparison of efficacy and side effects in the treatment of mild to moderate hypertension.
    Bochsler JA, Simmons RL, Ward PJ, Chester PC, Latham AN.
    J Hum Hypertens; 1988 Mar; 1(4):305-10. PubMed ID: 3065507
    [Abstract] [Full Text] [Related]

  • 7. Twice-daily administration of oral verapamil in the treatment of essential hypertension.
    Frishman W, Charlap S, Kimmel B, Saltzberg S, Stroh J, Weinberg P, Monuszko E, Wiezner J, Dorsa F, Pollack S.
    Arch Intern Med; 1986 Mar; 146(3):561-5. PubMed ID: 3954530
    [Abstract] [Full Text] [Related]

  • 8. Comparisons of verapamil administration twice and three times daily in hypertension.
    Salmela PI, Gordin A, Salo H, Ottoila P, Jounela AJ.
    Ann Clin Res; 1988 Mar; 20(3):195-200. PubMed ID: 3058014
    [Abstract] [Full Text] [Related]

  • 9. [Comparison of the efficacy and tolerability of sustained-release verapamil and captopril in mild to moderate essential arterial hypertension].
    Maarek-Charbit M, Stephan D, Welsch M, Galey-Arcangioli C, Imbs JL.
    Ann Cardiol Angeiol (Paris); 1991 Oct; 40(8):509-13. PubMed ID: 1759789
    [Abstract] [Full Text] [Related]

  • 10. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
    Svetkey LP, Weinberger MH, Gavras H, Gavras I, Brown TS, Deterding J, Klotman PE.
    J Clin Hypertens; 1987 Dec; 3(4):579-88. PubMed ID: 3330988
    [Abstract] [Full Text] [Related]

  • 11. Population analyses of sustained-release verapamil in patients: effects of sex, race, and smoking.
    Kang D, Verotta D, Krecic-Shepard ME, Modi NB, Gupta SK, Schwartz JB.
    Clin Pharmacol Ther; 2003 Jan; 73(1):31-40. PubMed ID: 12545141
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of sustained-release verapamil: automatic ambulatory blood pressure monitoring.
    Zachariah PK, Sheps SG, Schriger A.
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):133S-142S. PubMed ID: 3540223
    [Abstract] [Full Text] [Related]

  • 13. [Sustained-released verapamil and ambulatory recording of blood pressure in mild to moderate essential hypertension].
    Bernadet P, Suc JM, Durand D, Galey C, Maarek-Charbit M.
    Ann Cardiol Angeiol (Paris); 1992 Feb; 41(2):105-12. PubMed ID: 1562157
    [Abstract] [Full Text] [Related]

  • 14. [Sustained release verapamil in essential hypertension].
    Yodfat Y, Nusbaum M, Gibor Y.
    Harefuah; 1991 May 15; 120(10):581-4. PubMed ID: 1937192
    [Abstract] [Full Text] [Related]

  • 15. Verapamil versus nifedipine in slow-release preparations for the treatment of mild to moderate hypertension.
    Shamiss A, Meisel S, Nussinovitch N, Rosenthal T.
    J Hum Hypertens; 1990 Aug 15; 4(4):465-8. PubMed ID: 2258895
    [Abstract] [Full Text] [Related]

  • 16. Comparison of sustained release verapamil and hydrochlorothiazide in hypertension--effect on blood pressure and metabolic variables.
    Lehtonen A, Gordin A, Salo H.
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun 15; 25(6):301-5. PubMed ID: 3623734
    [Abstract] [Full Text] [Related]

  • 17. [Controlled study on the treatment of hypertension with verapamil in retard form].
    Belz GG, Spies G.
    Z Kardiol; 1985 Aug 15; 74(8):453-9. PubMed ID: 3901562
    [Abstract] [Full Text] [Related]

  • 18. [Comparative efficacy of sustained release verapamil and captopril in mild to moderate arterial hypertension by ambulatory measurement and occasional measurement].
    Drici MD, Teboul B, Lapalus P, Morand P, Atlan JP, Bouche JM, Ceccaldi JP, Giacomoni S, Halimi G, Passeron-Seître M.
    Ann Cardiol Angeiol (Paris); 1991 Nov 15; 40(9):567-70. PubMed ID: 1776803
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.